Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
June 05, 2024 11:55 ET
|
Block & Leviton LLP
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
Grayscale Investments® Announces CEO Transition
May 20, 2024 09:00 ET
|
Grayscale Investments
Grayscale Investments® Announces CEO Transition
Peter Mintzberg Appointed Grayscale’s CEO, Effective August 15, 2024
Zero Hash Honored by Goldman Sachs for Entrepreneurship
October 18, 2023 09:00 ET
|
Zero Hash
CHICAGO, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Today, Goldman Sachs (NYSE:GS) is recognizing Zero Hash Founder and CEO, Edward Woodford as one of the Most Exceptional Entrepreneurs of 2023 at its...
Recursion to Participate in Upcoming Investor Conference
August 01, 2023 08:30 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Myriad Genetics to Participate in Goldman Sachs Healthcare Conference
June 07, 2023 16:05 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, June 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, president and CEO, will...
InnovAge Announces Participation at the 44th Annual Goldman Sachs Global Healthcare Conference
June 05, 2023 08:00 ET
|
InnovAge
DENVER, June 05, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail seniors...
Recursion to Participate in Upcoming Investor Conferences
June 01, 2023 08:30 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in...
Revolution Medicines to Participate in TD Cowen 4th Annual Oncology Innovation Summit
May 24, 2023 16:05 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
Micron Technology Announces Upcoming Investor Events
May 04, 2023 16:01 ET
|
Micron Technology, Inc.
BOISE, Idaho, May 04, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), announced today that company executives will participate in fireside chats at the following investor events: ...